Skip to main content
. 2020 Jul 10;11(4):866–886. doi: 10.1002/jcsm.12587

TABLE 2.

Association between impaired muscle strength/function and PAD

Reference Patients population Number of patients/controls Assessment method Main results
Muscle strength Muscle mass/quality Physical performance

Kakihana et al., 2017, J Vasc Surg

35

PAD 16/10 7‐m walkway embedded with a force plate test PAD was associated with slower walk at self‐selected walking speed (88.32 ± 15.15 cm/s for PAD patients vs. 126.04 ± 16.31 cm/s for controls, P < 0.001) and at fast walking speed (119.90 ± 21.07 cm/s vs. 162.01 ± 21.47 cm/s for controls, P < 0.001); lower cadence at self‐selected walking speed (109.92 ± 12.17 step/min vs. 118.38 ± 7.28 steps/min, P < 0.001) and at fast walking speed (121.29 ± 11.39 steps/min vs. 135.11 ± 9.47 step/min, P < 0.001); and reduced peak hip flexor generation power at self‐selected walking speed (0.50 ± 0.18 W/kg vs. 1.00 ± 0.22 W/kg, P < 0.001) and at fast walking speed (0.78 ± 0.27 W/kg vs. 1.40 ± 0.39 W/kg, P < 0.001)

Schieber et al., 2017, J Vasc Surg

29

PAD 94/16 Maximal isometric plantar flexion contractions of 10 s PAD patients exhibited strength deficits, with impaired peak torque values (69.1 ± 28.7 N.m for claudicating patients vs. 98.2 ± 27.6 N.m for controls, P < 0.01)

Dziubek et al., 2015, Maturitas

33

CLI 85/50 Force‐velocity parameters (peak torque, total work, average power) of the lower limb 6‐min walk test PAD was associated with lower 6‐min walk distance (349.77 ± 65.08 m for PAD patients vs. 515.86 ± 96.39 for controls, P < 0.0001), lower mean walk speed (3.49 ± 0.65 km/h vs. 5.15 ± 0.96 km/h for controls, P < 0.01), and significantly lower values of force‐velocity parameters (including peak torque, total work and average power of the knee joint) compared with the control group (P < 0.005)

Parmenter et al., 2013, J Vasc Surg

34

PAD 22/− Maximum strength/endurance testing (hip extensors, hip abductors, quadriceps, hamstrings, plantar flexors, pectoral, upper back muscles) 6‐min walk test Greater severity of PAD was associated with reduced bilateral hip extensor strength (r = 0.54, P = 0.007), whole body strength (r = 0.32, P = 0.05), shorter distance to first stop during the 6‐min walk test (r = 0.38, P = 0.05) and poorer single leg balance (r = 0.44, P = 0.03) (using univariate and stepwise multiple regression models)

Câmara et al., 2012, Ann Vasc Surg

30

PAD 20/9 Plantar flexion/dorsiflexion movements, knee extension/flexion movements Plantar flexion/dorsiflexion movements, knee extension/flexion movements

PAD patients presented lower muscle strength in dorsiflexion (0.20 ± 0.10 N/m/kg for PAD patients vs. 0.29 ± 0.10 N/m/kg for controls, P < 0.01), plantar flexion (0.36 ± 0.20 N/m/kg vs. 0.53 ± 0.20 N/m/kg, P < 0.01) and knee flexion movements (0.50 ± 0.30 N/m/kg vs. 0.62 ± 0.10, P = 0.04).

Also, PAD was associated with lower muscle endurance in dorsiflexion (8.0 ± 3.5 N/m/kg vs. 9.9 ± 6.6 N/m/kg, P = 0.01) and plantar flexion movements (20.0 ± 9.0 N/m/kg vs. 25.7 ± 10.7 N/m/kg, P = 0.02)

Wurdeman et al., 2012, Gait Posture

31

PAD 30/32 Joint moments and powers at early, mid and late stance (hip and knee and ankle joints) PAD was associated with reduced peak hip power absorption in midstance (−0.788 ± 0.25 W/kg for PAD patients vs.−0.950 ± 0.27 W/kg for controls, P = 0.017), reduced peak knee power absorption in late stance (−0.729 ± 0.21 W/kg vs.−0.899 ± 0.33 W/kg for controls, P = 0.02), and reduced peak ankle power generation in late stance (2.677 ± 0.45 W/kg vs. 2.998 ± 0.60 W/kg, P = 0.021)

Koutakis et al., 2010, J Vasc Surg

32

PAD 20/16 Joint torques and powers at early, mid and late stance (hip, knee and ankle joints) Ambulation on a walkway

PAD patients presented significantly reduced hip power generation in late stance (0.569 ± 0.18 W/kg for claudicating patients vs. 0.706 ± 0.24 W/kg for controls, P = 0.03), knee power absorption in late stance (−0.580 ± 0.25 W/kg vs. −0.882 ± 0.32 W/kg, P = 0.0015), and ankle power generation in late stance (2.178 ± 0.51 W/kg vs. 2.957 ± 0.69 W/kg, P = 0.0001)

Also, PAD was associated with reduced gait velocity (1.09 ± 0.13 m/s for claudicating patients vs. 1.28 ± 0.13 m/s for controls, P = 0.0007) and stride length (1.27 ± 0.11 m vs. 1.47 ± 0.11 m for controls, P < 0.001)

Koutakis et al., 2010, J Vasc Surg

36

PAD 20/10 Joint torques and powers at early, mid and late stance (hip, knee and ankle joints) PAD was associated with reduced knee power generation in early stance (0.26 ± 0.31 W/kg for claudicating patients vs. 0.62 ± 0.25 W/kg for controls, P < 0.05) and ankle power generation in late stance (2.05 ± 0.59 W/kg vs. 4.00 ± 0.88 W/kg for controls, P < 0.05)

Herman et al., 2009, J Am Geriatr Soc

37

PAD 374/−

Hip extension/flexion, knee extension/flexion strength

Walking over a force platform

7‐m walking speed test

6‐min walk test

Short physical performance battery

In women with PAD, weaker baseline hip and knee flexion strength were associated with faster average annual decline in usual‐paced 4‐m walking velocity (P trend < 0.001 and P trend = 0.02 respectively) and in short physical performance battery test (P trend = 0.019 and P trend = 0.01, respectively)

McDermott et al., 2008, J Am Geriatr Soc

28

PAD 424/271

Isometric knee extension/plantar flexion strength

Handgrip strength

Knee extension power

6‐min walk test

4‐m walking velocity test

Lower arterial brachial index values were associated with lower plantar flexion strength (P trend = 0.04) and lower knee extension power (P trend < 0.001)

Kuo et al., 2008, J Gerontol A Biol Sci Med Sci

38

PAD 206/1592 Isokinetic dynamometer 20‐ft timed walk test PAD associated with weak leg force, low gait speed and functional dependence (based on multiple logistic regression analyses)